mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NC_000913_3_pae_pgi | 4,295,320 | 0 | C | T | 27.3% | 104.8 / 34.6 | 66 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
| * | NC_000913_3_pae_pgi | 526,796 | 0 | C | G | 26.2% | 115.6 / 38.2 | 61 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_pae_pgi | 526,792 | 0 | A | C | 26.2% | 98.4 / 35.0 | 65 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_pae_pgi | 2,383,959 | 0 | A | T | 26.1% | 20.5 / 15.0 | 23 | intergenic (+35/+36) | elaD/yfbK | protease, capable of cleaving an AMC‑ubiquitin model substrate/Von Willebrand factor domain putative lipoprotein |
| * | NC_000913_3_pae_pgi | 526,800 | 0 | A | G | 24.6% | 102.9 / 20.6 | 57 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_pae_pgi | 2,383,956 | 0 | A | T | 22.2% | 38.7 / 14.0 | 27 | intergenic (+32/+39) | elaD/yfbK | protease, capable of cleaving an AMC‑ubiquitin model substrate/Von Willebrand factor domain putative lipoprotein |
| Marginal new junction evidence (lowest skew 10 of 196 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913_3_pae_pgi | = 1066842 | 39 (0.970) | 8 (0.210) | 8/260 | 3.6 | 17.9% | intergenic (+16/+22) | agp/yccJ | glucose‑1‑phosphatase/inositol phosphatase/uncharacterized protein |
| ? | NC_000913_3_pae_pgi | = 1066847 | 37 (0.990) | intergenic (+21/+17) | agp/yccJ | glucose‑1‑phosphatase/inositol phosphatase/uncharacterized protein | |||||
| * | ? | NC_000913_3_pae_pgi | = 4331354 | NA (NA) | 6 (0.160) | 6/260 | 4.3 | 16.2% | intergenic (+90/‑22) | proP/pmrR | proline/glycine betaine transporter/putative membrane‑bound BasS regulator |
| ? | NC_000913_3_pae_pgi | = 4331362 | 31 (0.830) | intergenic (+98/‑14) | proP/pmrR | proline/glycine betaine transporter/putative membrane‑bound BasS regulator | |||||
| * | ? | NC_000913_3_pae_pgi | 381292 = | NA (NA) | 6 (0.160) | 6/262 | 4.3 | NA | intergenic (‑32/‑59) | yaiX/insC1 | pseudogene, interrupted by IS2A; hexapeptide transferase superfamily; putative transferase/IS2 repressor TnpA |
| ? | NC_000913_3_pae_pgi | 381312 = | NA (NA) | intergenic (‑52/‑39) | yaiX/insC1 | pseudogene, interrupted by IS2A; hexapeptide transferase superfamily; putative transferase/IS2 repressor TnpA | |||||
| * | ? | NC_000913_3_pae_pgi | 3792754 = | 35 (0.870) | 5 (0.130) | 5/258 | 4.7 | 13.7% | intergenic (‑203/+72) | kbl/yibB | glycine C‑acetyltransferase/YibB family protein, function unknown |
| ? | NC_000913_3_pae_pgi | 3792780 = | 31 (0.840) | intergenic (‑229/+46) | kbl/yibB | glycine C‑acetyltransferase/YibB family protein, function unknown | |||||
| * | ? | NC_000913_3_pae_pgi | = 1904769 | 35 (0.870) | 5 (0.130) | 5/266 | 4.8 | 13.1% | intergenic (+23/‑32) | manZ/yobD | mannose‑specific enzyme IID component of PTS/UPF0266 family inner membrane protein |
| ? | NC_000913_3_pae_pgi | = 1904773 | 33 (0.860) | intergenic (+27/‑28) | manZ/yobD | mannose‑specific enzyme IID component of PTS/UPF0266 family inner membrane protein | |||||
| * | ? | NC_000913_3_pae_pgi | = 2325653 | 38 (0.940) | 5 (0.130) | 5/268 | 4.9 | 11.7% | coding (898/1323 nt) | atoE | short chain fatty acid transporter |
| ? | NC_000913_3_pae_pgi | = 2325662 | 39 (1.010) | coding (907/1323 nt) | atoE | short chain fatty acid transporter | |||||
| * | ? | NC_000913_3_pae_pgi | = 2305015 | 56 (1.390) | 5 (0.160) +33 bp |
3/214 | 4.9 | 10.5% | noncoding (599/655 nt) | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences |
| ? | NC_000913_3_pae_pgi | = 2305065 | NA (NA) | noncoding (649/655 nt) | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | REP161 (repetitive extragenic palindromic) element; contains 12 REP sequences | |||||
| * | ? | NC_000913_3_pae_pgi | 1552071 = | NA (NA) | 4 (0.110) | 4/256 | 5.1 | NA | noncoding (1/97 nt) | RIP120 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | RIP120 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site |
| ? | NC_000913_3_pae_pgi | 1552279 = | NA (NA) | noncoding (31/97 nt) | RIP121 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | RIP121 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | |||||
| * | ? | NC_000913_3_pae_pgi | 1343551 = | 48 (1.190) | 4 (0.110) | 4/256 | 5.1 | 8.3% | intergenic (‑223/+46) | osmB/yciT | osmotically and stress inducible lipoprotein/global regulator of transcription; DeoR family |
| ? | NC_000913_3_pae_pgi | 1343581 = | 44 (1.200) | intergenic (‑253/+16) | osmB/yciT | osmotically and stress inducible lipoprotein/global regulator of transcription; DeoR family | |||||
| * | ? | NC_000913_3_pae_pgi | = 3980725 | 57 (1.420) | 4 (0.110) | 4/258 | 5.2 | 7.0% | intergenic (+29/‑162) | wecG/yifK | UDP‑N‑acetyl‑D‑mannosaminuronic acid transferase/putative APC family amino acid transporter |
| ? | NC_000913_3_pae_pgi | = 3980727 | 53 (1.430) | intergenic (+31/‑160) | wecG/yifK | UDP‑N‑acetyl‑D‑mannosaminuronic acid transferase/putative APC family amino acid transporter | |||||